Ninang, Arvy B.

HRN: 17-35-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2025
CEFUROXIME 750MG (VIAL)
07/20/2025
07/27/2025
IV
750mg
Q8
PCAP C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: